Medicare Enrolled

Dr. Jose Rosado, M.D.

Cardiovascular Disease · Leesburg, FL
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Speaking/Promotional
511 MEDICAL PLAZA DR, Leesburg, FL 34748
3527286808
In practice since 2005 (20 years)
NPI: 1417940404 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosado from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosado? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosado

Dr. Jose Rosado is a cardiovascular disease in Leesburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Rosado performed 5,525 Medicare services across 2,647 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosado received a total of $29,306 from 42 pharmaceutical and/or device companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosado is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 18% volume in FL$ $29,306 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,525
Medicare services
Top 18% in FL for cardiovascular disease
2,647
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~276 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,243$87$338
Contrast dye for imaging (iodine-based)1,101$0$1
Electrocardiogram (EKG), 12-lead700$10$65
Remote pacemaker/defibrillator monitoring, 90 days342$15$74
Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services339$20$76
Remote pacemaker monitoring, 90 days270$21$100
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional230$13$60
Prothrombin time test (blood clotting)194$4$16
Anticoagulant management of patient taking warfarin189$9$35
Programming of dual lead pacemaker system106$53$190
Office visit, established patient (20-29 min)93$57$232
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days72$26$181
Echocardiogram, transthoracic69$130$648
Injection, midazolam hydrochloride, per 1 mg69$0$1
Hospital follow-up visit, moderate complexity66$63$224
Office visit, established patient, complex (40-54 min)63$121$456
New patient office visit (45-59 min)53$120$499
Injection, fentanyl citrate, 0.1 mg39$1$2
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes30$9$33
Programming of single lead pacemaker system29$47$161
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional27$20$80
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes24$38$152
Initial hospital admission, moderate complexity20$103$416
Programming of multiple lead implantable defibrillator system18$74$279
Ultrasound of heart with probe in esophagus, with report16$154$730
Ultrasound of heart with color-depicted blood flow, rate and valve function16$18$290
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician15$16$67
Exercise or drug-induced heart stress test with electrocardiogram (ecg)15$21$113
New patient office visit (30-44 min)15$70$328
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician14$51$224
Ultrasound of heart blood flow, valves and chambers13$39$159
Ultrasound of both sides of head and neck blood flow12$119$598
Initial hospital admission, high complexity12$137$620
Infusion, normal saline solution, 250 cc11$1$2
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.1% high complexity
23.2% medium
59.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$29,306
Total received (2018-2024)
Avg $4,187/year across 7 years
Top 11% in FL for cardiovascular disease
42
Companies
315
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20,073 (68.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,232 (31.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,922
2023
$822
2022
$516
2021
$1,277
2020
$3,338
2019
$8,270
2018
$12,161

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$20,123
Boston Scientific Corporation
$1,682
CVRx, Inc.
$1,356
W. L. Gore & Associates, Inc.
$1,250
Tosoh Bioscience, Inc.
$556
Medtronic, Inc.
$525
Esperion Therapeutics, Inc.
$341
Medtronic Vascular, Inc.
$282
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$242
AstraZeneca Pharmaceuticals LP
$197
Braemar Manufacturing, LLC
$197
Takeda Pharmaceuticals U.S.A., Inc.
$195
BOSTON SCIENTIFIC CORPORATION
$190
Amgen Inc.
$185
Merck Sharp & Dohme LLC
$161
Abbott Laboratories
$157
Inari Medical, Inc.
$154
SANOFI-AVENTIS U.S. LLC
$148
Canon Medical Systems USA, Inc.
$148
Edwards Lifesciences Corporation
$145
Merck Sharp & Dohme Corporation
$119
Janssen Pharmaceuticals, Inc
$118
PFIZER INC.
$118
Penumbra, Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Amarin Pharma Inc.
$75
E.R. Squibb & Sons, L.L.C.
$63
Alnylam Pharmaceuticals Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$43
Philips Electronics North America Corporation
$38
Arrow International, Inc.
$31
Novo Nordisk Inc
$30
Aries Pharmaceuticals, Inc.
$30
Teleflex LLC
$30
Kestra Medical Technology Services, Inc.
$23
Arrow Interventional, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$17
Actelion Pharmaceuticals US, Inc.
$16
SCPHARMACEUTICALS INC.
$15
Kowa Pharmaceuticals America, Inc.
$14
GE HEALTHCARE
$11
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 79.0% of total payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · AIA-PACK · ANGIOJET · Amplia MRI · Assure WCD · BELSOMRA · BRILINTA · Barostim Neo System · CAMZYOS · CAROTID WALLSTENT · CHANTIX · Cardiac Monitoring Suite · ClosureFast · Conformable TAG Thoracic Endoprosthesis · ELEVIEW · ELIQUIS · ELUVIA · ENDURANT IIS · ENTRESTO · EPIC VASCULAR · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Entyvio · FATHOM · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL ATHERECTOMY · GENERAL ATHERECTOMY · GENERAL THROMBECTOMY · GENERAL - ATHERECTOMY · GENERAL - STRUCTURAL HEART · GENERAL ATHERECTOMY · GENERAL GUIDEWIRES · GENERAL ULTRASOUND · GORE VIABAHN Endoprosthesis with Heparin · GORE VIABAHN VBX Balloon Expandable Endo · Guidewires · Hemostasis - Topical Patches · ILAB · Indigo System · Interventional Products · JARDIANCE · JETSTREAM · Kerendia · LEQVIO · LifeVest · Livalo · MITRACLIP · MULTAQ · MYLUX · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · RESOLUTE ONYX · Radial Access - Other Radial Products · Repatha · Resolute · Reveal LINQ · S · SQ-RX PULSE GENERATOR · ST AIA-PACK · SYMPLICITY G3 · TSH · TSH3G · VENOUS WALLSTENT · VERQUVO · VIABAHN Endoprosthesis · VIABAHN Endoprosthesis with Heparin Bioactive Surface · VYNDAQEL · Varithena Administration Pack · Vascepa · Vein Treatment - VariLase · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $530 per 100 Medicare services performed
Looking for a cardiovascular disease in Leesburg?
Compare cardiovascular diseases in the Leesburg area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
53
Per 100K population
13.3
County median income
$69,956
Nearest hospital
UF HEALTH LEESBURG HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rosado is a electrophysiology & remote specialist, with above-average Medicare volume (top 18% in FL), and high industry engagement (speaking/promotional, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rosado experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rosado performed 1,243 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosado receive payments from pharmaceutical companies?
Yes. Dr. Rosado received a total of $29,306 from 42 companies across 315 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosado's costs compare to other cardiovascular diseases in Leesburg?
Dr. Rosado's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosado) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →